These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
355 related items for PubMed ID: 31397065
1. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma. Buszek SM, Ludmir EB, Grosshans DR, McAleer MF, McGovern SL, Harrison DJ, Okcu MF, Chintagumpala MM, Mahajan A, Paulino AC. Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065 [Abstract] [Full Text] [Related]
2. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma. Buszek SM, Ludmir EB, Grosshans DR, McAleer MF, McGovern SL, Harrison DJ, Okcu MF, Chintagumpala MM, Mahajan A, Paulino AC. Int J Radiat Oncol Biol Phys; 2021 Mar 01; 109(3):718-725. PubMed ID: 33516439 [Abstract] [Full Text] [Related]
3. Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery. Heinzelmann F, Thorwarth D, Lamprecht U, Kaulich TW, Fuchs J, Seitz G, Ebinger M, Handgretinger R, Bamberg M, Weinmann M. Strahlenther Onkol; 2011 Nov 01; 187(11):715-21. PubMed ID: 22037652 [Abstract] [Full Text] [Related]
9. Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group. Wolden SL, Lyden ER, Arndt CA, Hawkins DS, Anderson JR, Rodeberg DA, Morris CD, Donaldson SS. Int J Radiat Oncol Biol Phys; 2015 Dec 01; 93(5):1071-6. PubMed ID: 26581144 [Abstract] [Full Text] [Related]
10. Parameningeal rhabdomyosarcoma: outcomes and opportunities. Yang JC, Wexler LH, Meyers PA, Wolden SL. Int J Radiat Oncol Biol Phys; 2013 Jan 01; 85(1):e61-6. PubMed ID: 23021437 [Abstract] [Full Text] [Related]
11. Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma. Ludmir EB, Grosshans DR, McAleer MF, McGovern SL, Harrison DJ, Okcu MF, Chintagumpala MM, Mahajan A, Paulino AC. Radiother Oncol; 2019 May 01; 134():143-150. PubMed ID: 31005208 [Abstract] [Full Text] [Related]
14. Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood. Douglas JG, Arndt CA, Hawkins DS. Eur J Cancer; 2007 Apr 01; 43(6):1045-50. PubMed ID: 17368885 [Abstract] [Full Text] [Related]
15. Primary chemotherapy for children with rhabdomyosarcoma of the 'special pelvic' sites: is preservation of the bladder possible? Kamii Y, Taguchi N, Tsunematsu Y, Kakizawa Y, Saeki M, Honna T, Nakano M, Hashizume K, Komuro H, Bessho F. J Pediatr Surg; 1994 Mar 01; 29(3):461-4. PubMed ID: 8201521 [Abstract] [Full Text] [Related]
16. Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study. Breneman J, Meza J, Donaldson SS, Raney RB, Wolden S, Michalski J, Laurie F, Rodeberg DA, Meyer W, Walterhouse D, Hawkins DS. Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):720-6. PubMed ID: 22104356 [Abstract] [Full Text] [Related]
17. 45 GyRBE for group III orbital embryonal rhabdomyosarcoma. Indelicato DJ, Rotondo RL, Mailhot Vega RB, Uezono H, Bradfield S, Agarwal V, Hol ML, Bradley JA. Acta Oncol; 2019 Oct 01; 58(10):1404-1409. PubMed ID: 31530120 [Abstract] [Full Text] [Related]
19. Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group. Lin C, Donaldson SS, Meza JL, Anderson JR, Lyden ER, Brown CK, Morano K, Laurie F, Arndt CA, Enke CA, Breneman JC. Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1764-70. PubMed ID: 21470795 [Abstract] [Full Text] [Related]